Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
PLoS Med
    February 2021
  1. POLITCH JA, Cu-Uvin S, Moench TR, Tashima KT, et al
    Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.
    PLoS Med. 2021;18:e1003495.
    >> Share

  2. KOSS CA, Havlir DV, Ayieko J, Kwarisiima D, et al
    HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003492.
    >> Share

    January 2021
  3. CHANG LW, Mbabali I, Hutton H, Amico KR, et al
    Novel community health worker strategy for HIV service engagement in a hyperendemic community in Rakai, Uganda: A pragmatic, cluster-randomized trial.
    PLoS Med. 2021;18:e1003475.
    >> Share

  4. MEFFERT SM, Neylan TC, McCulloch CE, Blum K, et al
    Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: Randomized controlled trial.
    PLoS Med. 2021;18:e1003468.
    >> Share

  5. STELZLE D, Godfrey-Faussett P, Jia C, Amiesimaka O, et al
    Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.
    PLoS Med. 2021;18:e1003482.
    >> Share

    December 2020
  6. RICKS S, Denkinger CM, Schumacher SG, Hallett TB, et al
    The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis.
    PLoS Med. 2020;17:e1003466.
    >> Share

  7. HAUSER A, Kusejko K, Johnson LF, Gunthard HF, et al
    Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.
    PLoS Med. 2020;17:e1003397.
    >> Share

    November 2020
  8. SCULIER D, Wandeler G, Yerly S, Marinosci A, et al
    Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
    PLoS Med. 2020;17:e1003421.
    >> Share

  9. BAIK Y, Rickman HM, Hanrahan CF, Mmolawa L, et al
    A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
    PLoS Med. 2020;17:e1003420.
    >> Share

  10. PSIHOPAIDAS D, Cohen SM, West T, Avery L, et al
    Implementation science and the Health Resources and Services Administration's Ryan White HIV/AIDS Program's work towards ending the HIV epidemic in the United States.
    PLoS Med. 2020;17:e1003128.
    >> Share

  11. ASGARY R, Staderini N, Mthethwa-Hleta S, Lopez Saavedra PA, et al
    Evaluating smartphone strategies for reliability, reproducibility, and quality of VIA for cervical cancer screening in the Shiselweni region of Eswatini: A cohort study.
    PLoS Med. 2020;17:e1003378.
    >> Share

    October 2020
  12. ZHANG C, Koniak-Griffin D, Qian HZ, Goldsamt LA, et al
    Impact of providing free HIV self-testing kits on frequency of testing among men who have sex with men and their sexual partners in China: A randomized controlled trial.
    PLoS Med. 2020;17:e1003365.
    >> Share

  13. YAPA HM, De Neve JW, Chetty T, Herbst C, et al
    The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial.
    PLoS Med. 2020;17:e1003150.
    >> Share

  14. BERNARD CL, Rao IJ, Robison KK, Brandeau ML, et al
    Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.
    PLoS Med. 2020;17:e1003239.
    >> Share

    September 2020
  15. ABDULLAHI SA, Smelyanskaya M, John S, Adamu HI, et al
    Providing TB and HIV outreach services to internally displaced populations in Northeast Nigeria: Results of a controlled intervention study.
    PLoS Med. 2020;17:e1003218.
    >> Share

  16. AMSTUTZ A, Nsakala BL, Vanobberghen F, Muhairwe J, et al
    Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    PLoS Med. 2020;17:e1003325.
    >> Share

  17. BEATTIE TS, Smilenova B, Krishnaratne S, Mazzuca A, et al
    Mental health problems among female sex workers in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003297.
    >> Share

    August 2020
  18. SHARMA V, Leight J, Verani F, Tewolde S, et al
    Effectiveness of a culturally appropriate intervention to prevent intimate partner violence and HIV transmission among men, women, and couples in rural Ethiopia: Findings from a cluster-randomized controlled trial.
    PLoS Med. 2020;17:e1003274.
    >> Share

  19. MASKEW M, Brennan AT, Fox MP, Vezi L, et al
    A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
    PLoS Med. 2020;17:e1003226.
    >> Share

    July 2020
  20. ROY M, Bolton-Moore C, Sikazwe I, Mukumbwa-Mwenechanya M, et al
    Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial.
    PLoS Med. 2020;17:e1003116.
    >> Share

  21. JONES AA, Gicas KM, Seyedin S, Willi TS, et al
    Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada.
    PLoS Med. 2020;17:e1003172.
    >> Share

    May 2020
  22. BROGER T, Nicol MP, Szekely R, Bjerrum S, et al
    Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.
    PLoS Med. 2020;17:e1003113.
    >> Share

  23. ROKX C, Borjas Howard JF, Smit C, Wit FW, et al
    Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    PLoS Med. 2020;17:e1003101.
    >> Share

  24. KERKHOFF AD, Sikombe K, Eshun-Wilson I, Sikazwe I, et al
    Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    PLoS Med. 2020;17:e1003107.
    >> Share

  25. KLEIN PW, Psihopaidas D, Xavier J, Cohen SM, et al
    HIV-related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the Health Resources and Services Administration's Ryan White HIV/AIDS Program: A retrospective study.
    PLoS Med. 2020;17:e1003125.
    >> Share

  26. MOODIE Z, Walsh SR, Laher F, Maganga L, et al
    Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
    PLoS Med. 2020;17:e1003117.
    >> Share

  27. TODD CS, Jones HE, Langwenya N, Hoover DR, et al
    Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
    PLoS Med. 2020;17:e1003110.
    >> Share

    April 2020
  28. FLOYD S, Shanaube K, Yang B, Schaap A, et al
    HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    PLoS Med. 2020;17:e1003067.
    >> Share

  29. CHAN SS, Chappel AR, Maddox KEJ, Hoover KW, et al
    Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
    PLoS Med. 2020;17:e1003072.
    >> Share

  30. KRETZSCHMAR MEE, van der Sande MAB
    Hepatitis B prevention: Can we learn from the response to HIV/AIDS?
    PLoS Med. 2020;17:e1003109.
    >> Share

  31. MCNAUGHTON AL, Lourenco J, Bester PA, Mokaya J, et al
    Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003068.
    >> Share

    March 2020
  32. BULSTRA CA, Hontelez JAC, Giardina F, Steen R, et al
    Mapping and characterising areas with high levels of HIV transmission in sub-Saharan Africa: A geospatial analysis of national survey data.
    PLoS Med. 2020;17:e1003042.
    >> Share

  33. DOHERTY M, Power L, Petrova M, Gunn S, et al
    Illness-related suffering and need for palliative care in Rohingya refugees and caregivers in Bangladesh: A cross-sectional study.
    PLoS Med. 2020;17:e1003011.
    >> Share

  34. GRIFFIN A, Dempsey A, Cousino W, Avery L, et al
    Addressing disparities in the health of persons with HIV attributable to unstable housing in the United States: The role of the Ryan White HIV/AIDS Program.
    PLoS Med. 2020;17:e1003057.
    >> Share

  35. MARUKUTIRA T, Gray RT, Douglass C, El-Hayek C, et al
    Gaps in the HIV diagnosis and care cascade for migrants in Australia, 2013-2017: A cross-sectional study.
    PLoS Med. 2020;17:e1003044.
    >> Share

  36. PEZZI C, Lee D, Kumar GS, Kawasaki B, et al
    Health screenings administered during the domestic medical examination of refugees and other eligible immigrants in nine US states, 2014-2016: A cross-sectional analysis.
    PLoS Med. 2020;17:e1003065.
    >> Share

  37. KIM HY, Dobra A, Tanser F
    Migration and first-year maternal mortality among HIV-positive postpartum women: A population-based longitudinal study in rural South Africa.
    PLoS Med. 2020;17:e1003085.
    >> Share

  38. KUMAR GS, Pezzi C, Wien S, Mamo B, et al
    Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis.
    PLoS Med. 2020;17:e1003083.
    >> Share

  39. JANDA A, Eder K, Fressle R, Geweniger A, et al
    Comprehensive infectious disease screening in a cohort of unaccompanied refugee minors in Germany from 2016 to 2017: A cross-sectional study.
    PLoS Med. 2020;17:e1003076.
    >> Share

  40. STEWARD WT, Koester KA, Guze MA, Kirby VB, et al
    Practice transformations to optimize the delivery of HIV primary care in community healthcare settings in the United States: A program implementation study.
    PLoS Med. 2020;17:e1003079.
    >> Share

    February 2020
  41. FORD N, Geng E, Ellman T, Orrell C, et al
    Emerging priorities for HIV service delivery.
    PLoS Med. 2020;17:e1003028.
    >> Share

  42. LIENHARDT C, Nunn A, Chaisson R, Vernon AA, et al
    Advances in clinical trial design: Weaving tomorrow's TB treatments.
    PLoS Med. 2020;17:e1003059.
    >> Share

  43. HERMANS LE, Carmona S, Nijhuis M, Tempelman HA, et al
    Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.
    PLoS Med. 2020;17:e1003037.
    >> Share

  44. LAHER F, Moodie Z, Cohen KW, Grunenberg N, et al
    Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    PLoS Med. 2020;17:e1003038.
    >> Share

    December 2019
  45. GENG EH, Holmes CB, Moshabela M, Sikazwe I, et al
    Personalized public health: An implementation research agenda for the HIV response and beyond.
    PLoS Med. 2019;16:e1003020.
    >> Share

    November 2019
  46. KENNEDY MC, Hayashi K, Milloy MJ, Wood E, et al
    Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
    PLoS Med. 2019;16:e1002964.
    >> Share

  47. MARKS C, Borquez A, Jain S, Sun X, et al
    Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis.
    PLoS Med. 2019;16:e1002973.
    >> Share

    October 2019
  48. ODENY TA, Hughes JP, Bukusi EA, Akama E, et al
    Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya.
    PLoS Med. 2019;16:e1002924.
    >> Share

  49. ELPHINSTONE RE, Weckman AM, McDonald CR, Tran V, et al
    Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
    PLoS Med. 2019;16:e1002914.
    >> Share

  50. BRIGDEN G, Nhung NV, Skrahina A, Ndjeka N, et al
    Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam.
    PLoS Med. 2019;16:e1002896.
    >> Share

  51. XU Y, Cancino-Munoz I, Torres-Puente M, Villamayor LM, et al
    High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain.
    PLoS Med. 2019;16:e1002961.
    >> Share

  52. MODY A, Eshun-Wilson I, Sikombe K, Schwartz SR, et al
    Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    PLoS Med. 2019;16:e1002959.
    >> Share

    September 2019
  53. LIENHARDT C, Vernon AA, Cavaleri M, Nambiar S, et al
    Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance.
    PLoS Med. 2019;16:e1002915.
    >> Share

  54. MUGWANYA KK, Pintye J, Kinuthia J, Abuna F, et al
    Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    PLoS Med. 2019;16:e1002885.
    >> Share

  55. ROSEN S, Maskew M, Larson BA, Brennan AT, et al
    Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
    PLoS Med. 2019;16:e1002912.
    >> Share

  56. AIBANA O, Huang CC, Aboud S, Arnedo-Pena A, et al
    Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis.
    PLoS Med. 2019;16:e1002907.
    >> Share

  57. WAITT C, Orrell C, Walimbwa S, Singh Y, et al
    Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
    PLoS Med. 2019;16:e1002895.
    >> Share

  58. DONALD KA, Wedderburn CJ, Barnett W, Nhapi RT, et al
    Risk and protective factors for child development: An observational South African birth cohort.
    PLoS Med. 2019;16:e1002920.
    >> Share

    August 2019
  59. GUPTA A, Hughes MD, Garcia-Prats AJ, McIntire K, et al
    Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
    PLoS Med. 2019;16:e1002882.
    >> Share

  60. SIKAZWE I, Eshun-Wilson I, Sikombe K, Czaicki N, et al
    Correction: Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    PLoS Med. 2019;16:e1002918.
    >> Share

  61. HOULE B, Rochat TJ, Newell ML, Stein A, et al
    Breastfeeding, HIV exposure, childhood obesity, and prehypertension: A South African cohort study.
    PLoS Med. 2019;16:e1002889.
    >> Share

    July 2019
  62. SCHUTZ C, Barr D, Andrade BB, Shey M, et al
    Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study.
    PLoS Med. 2019;16:e1002840.
    >> Share

  63. FOX MP, Pascoe S, Huber AN, Murphy J, et al
    Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
    PLoS Med. 2019;16:e1002874.
    >> Share

    June 2019
  64. ROGERS VAN KATWYK S, Grimshaw JM, Nkangu M, Nagi R, et al
    Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.
    PLoS Med. 2019;16:e1002819.
    >> Share

  65. TYMEJCZYK O, Brazier E, Yiannoutsos CT, Vinikoor M, et al
    Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
    PLoS Med. 2019;16:e1002822.
    >> Share

  66. ATUKUNDA EC, Mugyenyi GR, Obua C, Atuhumuza EB, et al
    Provision of family planning vouchers and early initiation of postpartum contraceptive use among women living with HIV in southwestern Uganda: A randomized controlled trial.
    PLoS Med. 2019;16:e1002832.
    >> Share

    May 2019
  67. GENG EH, Holmes CB
    Research to improve differentiated HIV service delivery interventions: Learning to learn as we do.
    PLoS Med. 2019;16:e1002809.
    >> Share

  68. EHRENKRANZ PD, Baptiste SL, Bygrave H, Ellman T, et al
    The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings.
    PLoS Med. 2019;16:e1002820.
    >> Share

  69. SIKAZWE I, Eshun-Wilson I, Sikombe K, Czaicki N, et al
    Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    PLoS Med. 2019;16:e1002811.
    >> Share

    April 2019
  70. GUPTA-WRIGHT A, Corbett EL, Wilson D, van Oosterhout JJ, et al
    Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    PLoS Med. 2019;16:e1002776.
    >> Share

  71. KAWASAKI M, Echiverri C, Raymond L, Cadena E, et al
    Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    PLoS Med. 2019;16:e1002780.
    >> Share

  72. MINERS A, Nadarzynski T, Witzel C, Phillips AN, et al
    Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment.
    PLoS Med. 2019;16:e1002779.
    >> Share

  73. PENN-NICHOLSON A, Hraha T, Thompson EG, Sterling D, et al
    Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
    PLoS Med. 2019;16:e1002781.
    >> Share

  74. HANRAHAN CF, Nonyane BAS, Mmolawa L, West NS, et al
    Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB).
    PLoS Med. 2019;16:e1002796.
    >> Share

  75. HUERGA H, Mathabire Rucker SC, Cossa L, Bastard M, et al
    Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/mul in 2 low-resource settings: A prospective observational study.
    PLoS Med. 2019;16:e1002792.
    >> Share

  76. GARCIA-PRATS AJ, Schaaf HS, Draper HR, Garcia-Cremades M, et al
    Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
    PLoS Med. 2019;16:e1002789.
    >> Share

    March 2019
  77. BOGAARDS JA, Mooij SH, Xiridou M, Schim van der Loeff MF, et al
    Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.
    PLoS Med. 2019;16:e1002756.
    >> Share

  78. GLADSTONE MJ, Chandna J, Kandawasvika G, Ntozini R, et al
    Independent and combined effects of improved water, sanitation, and hygiene (WASH) and improved complementary feeding on early neurodevelopment among children born to HIV-negative mothers in rural Zimbabwe: Substudy of a cluster-randomized trial.
    PLoS Med. 2019;16:e1002766.
    >> Share

  79. GELDSETZER P, Mboggo E, Larson E, Lema IA, et al
    Community health workers to improve uptake of maternal healthcare services: A cluster-randomized pragmatic trial in Dar es Salaam, Tanzania.
    PLoS Med. 2019;16:e1002768.
    >> Share

    February 2019
  80. BHATIA T, Enoch J, Khan M, Mathewson S, et al
    Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?
    PLoS Med. 2019;16:e1002735.
    >> Share

  81. SUBBARAMAN R, Nathavitharana RR, Mayer KH, Satyanarayana S, et al
    Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care.
    PLoS Med. 2019;16:e1002754.
    >> Share

  82. BANDSMA RHJ, Voskuijl W, Chimwezi E, Fegan G, et al
    A reduced-carbohydrate and lactose-free formulation for stabilization among hospitalized children with severe acute malnutrition: A double-blind, randomized controlled trial.
    PLoS Med. 2019;16:e1002747.
    >> Share

    January 2019
  83. CHOKO AT, Corbett EL, Stallard N, Maheswaran H, et al
    HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial.
    PLoS Med. 2019;16:e1002719.
    >> Share

  84. TENFORDE MW, Walker AS, Gibb DM, Manabe YC, et al
    Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach.
    PLoS Med. 2019;16:e1002723.
    >> Share

  85. LOW AJ, Frederix K, McCracken S, Manyau S, et al
    Association between severe drought and HIV prevention and care behaviors in Lesotho: A population-based survey 2016-2017.
    PLoS Med. 2019;16:e1002727.
    >> Share

  86. JONES J, Sullivan PS, Curran JW
    Progress in the HIV epidemic: Identifying goals and measuring success.
    PLoS Med. 2019;16:e1002729.
    >> Share

    December 2018
  87. KITYO C, Szubert AJ, Siika A, Heyderman R, et al
    Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
    PLoS Med. 2018;15:e1002706.
    >> Share

  88. PLATT L, Grenfell P, Meiksin R, Elmes J, et al
    Associations between sex work laws and sex workers' health: A systematic review and meta-analysis of quantitative and qualitative studies.
    PLoS Med. 2018;15:e1002680.
    >> Share

  89. AMON JJ, Eba P, Sprague L, Edwards O, et al
    Defining rights-based indicators for HIV epidemic transition.
    PLoS Med. 2018;15:e1002720.
    >> Share

    November 2018
  90. LANDOVITZ RJ, Li S, Grinsztejn B, Dawood H, et al
    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
    PLoS Med. 2018;15:e1002690.
    >> Share

  91. ALEXANDER KA, Heaney AK, Shaman J
    Hydrometeorology and flood pulse dynamics drive diarrheal disease outbreaks and increase vulnerability to climate change in surface-water-dependent populations: A retrospective analysis.
    PLoS Med. 2018;15:e1002688.
    >> Share

    October 2018
  92. LOELIGER KB, Meyer JP, Desai MM, Ciarleglio MM, et al
    Retention in HIV care during the 3 years following release from incarceration: A cohort study.
    PLoS Med. 2018;15:e1002667.
    >> Share

  93. GHYS PD, Williams BG, Over M, Hallett TB, et al
    Epidemiological metrics and benchmarks for a transition in the HIV epidemic.
    PLoS Med. 2018;15:e1002678.
    >> Share

    September 2018
  94. GELDSETZER P, Francis JM, Sando D, Asmus G, et al
    Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania.
    PLoS Med. 2018;15:e1002659.
    >> Share

  95. VINCENT KL, Moss JA, Marzinke MA, Hendrix CW, et al
    Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    PLoS Med. 2018;15:e1002655.
    >> Share

    August 2018
  96. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Correction: Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002643.
    >> Share

  97. ZANOLINI A, Sikombe K, Sikazwe I, Eshun-Wilson I, et al
    Understanding preferences for HIV care and treatment in Zambia: Evidence from a discrete choice experiment among patients who have been lost to follow-up.
    PLoS Med. 2018;15:e1002636.
    >> Share

  98. TANG W, Wei C, Cao B, Wu D, et al
    Crowdsourcing to expand HIV testing among men who have sex with men in China: A closed cohort stepped wedge cluster randomized controlled trial.
    PLoS Med. 2018;15:e1002645.
    >> Share

    July 2018
  99. HARAUSZ EP, Garcia-Prats AJ, Law S, Schaaf HS, et al
    Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    PLoS Med. 2018;15:e1002591.
    >> Share

    June 2018
  100. MODY A, Sikazwe I, Czaicki NL, Wa Mwanza M, et al
    Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
    PLoS Med. 2018;15:e1002574.
    >> Share

  101. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002589.
    >> Share

  102. TORRONE EA, Morrison CS, Chen PL, Kwok C, et al
    Correction: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
    PLoS Med. 2018;15:e1002608.
    >> Share

    May 2018
  103. DESMONDE S, Tanser F, Vreeman R, Takassi E, et al
    Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    PLoS Med. 2018;15:e1002565.
    >> Share

    March 2018
  104. PATEL P, Speight C, Maida A, Loustalot F, et al
    Integrating HIV and hypertension management in low-resource settings: Lessons from Malawi.
    PLoS Med. 2018;15:e1002523.
    >> Share

  105. SLOGROVE AL, Schomaker M, Davies MA, Williams P, et al
    The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
    PLoS Med. 2018;15:e1002514.
    >> Share

  106. MYER L, Phillips TK, Zerbe A, Brittain K, et al
    Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    PLoS Med. 2018;15:e1002547.
    >> Share

  107. STEKLER JD, Milne R, Payant R, Beck I, et al
    Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort.
    PLoS Med. 2018;15:e1002537.
    >> Share

  108. TYMEJCZYK O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, et al
    HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    PLoS Med. 2018;15:e1002534.
    >> Share

    February 2018
  109. TORRONE EA, Morrison CS, Chen PL, Kwok C, et al
    Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
    PLoS Med. 2018;15:e1002511.
    >> Share

  110. FRANCIS SC, Mthiyane TN, Baisley K, Mchunu SL, et al
    Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site.
    PLoS Med. 2018;15:e1002512.
    >> Share

    January 2018
  111. MARRAZZO JM, Dombrowski JC, Mayer KH
    Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.
    PLoS Med. 2018;15:e1002485.
    >> Share

  112. HOLMES CB, Sikazwe I, Sikombe K, Eshun-Wilson I, et al
    Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey.
    PLoS Med. 2018;15:e1002489.
    >> Share

  113. GAUDINSKI MR, Coates EE, Houser KV, Chen GL, et al
    Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
    PLoS Med. 2018;15:e1002493.
    >> Share

  114. JUDD A, Chappell E, Turkova A, Le Coeur S, et al
    Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    PLoS Med. 2018;15:e1002491.
    >> Share

    December 2017
  115. DUBE K, Sylla L, Dee L, Taylor J, et al
    Research on HIV cure: Mapping the ethics landscape.
    PLoS Med. 2017;14:e1002470.
    >> Share

  116. KENDALL EA, Schumacher SG, Denkinger CM, Dowdy DW, et al
    Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    PLoS Med. 2017;14:e1002472.
    >> Share

  117. SUTHAR AB, Barnighausen T
    Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy.
    PLoS Med. 2017;14:e1002469.
    >> Share

  118. JOHNSON LF, May MT, Dorrington RE, Cornell M, et al
    Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
    PLoS Med. 2017;14:e1002468.
    >> Share

  119. CHESANG K, Hornston S, Muhenje O, Saliku T, et al
    Healthcare provider perspectives on managing sexually transmitted infections in HIV care settings in Kenya: A qualitative thematic analysis.
    PLoS Med. 2017;14:e1002480.
    >> Share

  120. WILSON E, Free C, Morris TP, Syred J, et al
    Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial.
    PLoS Med. 2017;14:e1002479.
    >> Share

  121. JOHNSTON C, Magaret A, Roychoudhury P, Greninger AL, et al
    Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.
    PLoS Med. 2017;14:e1002475.
    >> Share

    November 2017
  122. CASTILLO P, Hurtado JC, Martinez MJ, Jordao D, et al
    Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study.
    PLoS Med. 2017;14:e1002431.
    >> Share

  123. MCNAIRY ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, et al
    Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial.
    PLoS Med. 2017;14:e1002420.
    >> Share

  124. BOYD MA, Mocroft A, Ryom L, Monforte AD, et al
    Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
    PLoS Med. 2017;14:e1002424.
    >> Share

  125. HENRICH TJ, Hatano H, Bacon O, Hogan LE, et al
    HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    PLoS Med. 2017;14:e1002417.
    >> Share

  126. KAPLAN SR, Oosthuizen C, Stinson K, Little F, et al
    Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
    PLoS Med. 2017;14:e1002407.
    >> Share

  127. EL-SADR WM, Harripersaud K, Rabkin M
    Reaching global HIV/AIDS goals: What got us here, won't get us there.
    PLoS Med. 2017;14:e1002421.
    >> Share

  128. POTEAT T, Ackerman B, Diouf D, Ceesay N, et al
    HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis.
    PLoS Med. 2017;14:e1002422.
    >> Share

  129. MAYER KH, Seaton KE, Huang Y, Grunenberg N, et al
    Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    PLoS Med. 2017;14:e1002435.
    >> Share

  130. SZUBERT AJ, Prendergast AJ, Spyer MJ, Musiime V, et al
    Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    PLoS Med. 2017;14:e1002432.
    >> Share

  131. MORRIS L, Mkhize NN
    Prospects for passive immunity to prevent HIV infection.
    PLoS Med. 2017;14:e1002436.
    >> Share

  132. KATZ IT, Kaplan R, Fitzmaurice G, Leone D, et al
    Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002434.
    >> Share

  133. ELUL B, Lamb MR, Lahuerta M, Abacassamo F, et al
    A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study.
    PLoS Med. 2017;14:e1002433.
    >> Share

  134. BARNABAS RV, Celum C
    Closing the gaps in the HIV care continuum.
    PLoS Med. 2017;14:e1002443.
    >> Share

  135. DUNNING L, Francke JA, Mallampati D, MacLean RL, et al
    The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
    PLoS Med. 2017;14:e1002446.
    >> Share

  136. CHANDA MM, Ortblad KF, Mwale M, Chongo S, et al
    HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial.
    PLoS Med. 2017;14:e1002442.
    >> Share

  137. EAKLE R, Gomez GB, Naicker N, Bothma R, et al
    HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    PLoS Med. 2017;14:e1002444.
    >> Share

  138. DEEKS SG, Lewin SR, Bekker LG
    The end of HIV: Still a very long way to go, but progress continues.
    PLoS Med. 2017;14:e1002466.
    >> Share

  139. BOR J, Fox MP, Rosen S, Venkataramani A, et al
    Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    PLoS Med. 2017;14:e1002463.
    >> Share

  140. SOLOMON SS, McFall AM, Lucas GM, Srikrishnan AK, et al
    Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    PLoS Med. 2017;14:e1002460.
    >> Share

  141. ORTBLAD K, Kibuuka Musoke D, Ngabirano T, Nakitende A, et al
    Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial.
    PLoS Med. 2017;14:e1002458.
    >> Share

  142. CUMMINS NW, Rizza S, Litzow MR, Hua S, et al
    Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    PLoS Med. 2017;14:e1002461.
    >> Share

  143. BEYRER C, Wirtz AL, O'Hara G, Leon N, et al
    The expanding epidemic of HIV-1 in the Russian Federation.
    PLoS Med. 2017;14:e1002462.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016